Different mutator phenotypes in Mlh1- versus Pms2-deficient mice

Xiang Yao, Andrew B. Buermeyer, Latha Narayanan, Doan Tran, Sean M. Baker, Tomas A. Prolla, Peter M. Glazer, Robert (Mike) Liskay, Norman Arnheim

Research output: Contribution to journalArticle

114 Citations (Scopus)

Abstract

Deficiencies in DNA mismatch repair (MMR) result in increased mutation rates and cancer risk in both humans and mice. Mouse strains homozygous for knockouts of either the Pms2 orMlh1 MMR gene develop cancer but exhibit very different tumor spectra; only Mlh1(-/-) animals develop intestinal tumors. We carried out a detailed study of the microsatellite mutation spectra in each knockout strain. Five mononucleotide repeat tracts at four different chromosomai locations were studied by using single-molecule PCR or an in vivo forward mutation assay. Three dinucleotide repeat loci also were examined. Surprisingly, the mononucleotide repeat mutation frequency in Mlh1(-/-) mice was 2- to 3-fold higher than in Pms2(-/-) animals. The higher mutation frequency in Mlh1(-/-) mice may be a consequence of some residual DNA repair capacity in the Pms2(-/-) animals. Relevant to this idea, we observed that Pms2(-/-) mice exhibit almost normal levels of Mlh1p, whereas Mlh1(-/-) animals lack both Mlh1p and Pms2p. Comparison between Mlh1(-/-) animals and Mlh1(-/-) and Pms2(-/-) double knockout mice revealed little difference in mutator phenotype, suggesting that Mlh1 nuilizygosity is sufficient to inactivate MMR completely. The findings may provide a basis for understanding the greater predisposition to intestinal cancer of Mlh1(-/-) mice. Small differences (2- to 3-fold) in mononucleotide repeat mutation rates may have dramatic effects on tumor development, requiring multiple genetic alterations in coding regions. Alternatively, this strain difference in tumor spectra also may be related to the consequences of the absence of Pms2p compared with the absence of both Pms2p and Mlh1p on as yet little understood cellular processes.

Original languageEnglish (US)
Pages (from-to)6850-6855
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume96
Issue number12
DOIs
StatePublished - Jun 8 1999

Fingerprint

Mutation Rate
Phenotype
DNA Mismatch Repair
Neoplasms
Dinucleotide Repeats
Intestinal Neoplasms
Mutation
Neoplasm Genes
Knockout Mice
DNA Repair
Microsatellite Repeats
Polymerase Chain Reaction

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Yao, X., Buermeyer, A. B., Narayanan, L., Tran, D., Baker, S. M., Prolla, T. A., ... Arnheim, N. (1999). Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. Proceedings of the National Academy of Sciences of the United States of America, 96(12), 6850-6855. https://doi.org/10.1073/pnas.96.12.6850

Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. / Yao, Xiang; Buermeyer, Andrew B.; Narayanan, Latha; Tran, Doan; Baker, Sean M.; Prolla, Tomas A.; Glazer, Peter M.; Liskay, Robert (Mike); Arnheim, Norman.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 96, No. 12, 08.06.1999, p. 6850-6855.

Research output: Contribution to journalArticle

Yao, X, Buermeyer, AB, Narayanan, L, Tran, D, Baker, SM, Prolla, TA, Glazer, PM, Liskay, RM & Arnheim, N 1999, 'Different mutator phenotypes in Mlh1- versus Pms2-deficient mice', Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 12, pp. 6850-6855. https://doi.org/10.1073/pnas.96.12.6850
Yao, Xiang ; Buermeyer, Andrew B. ; Narayanan, Latha ; Tran, Doan ; Baker, Sean M. ; Prolla, Tomas A. ; Glazer, Peter M. ; Liskay, Robert (Mike) ; Arnheim, Norman. / Different mutator phenotypes in Mlh1- versus Pms2-deficient mice. In: Proceedings of the National Academy of Sciences of the United States of America. 1999 ; Vol. 96, No. 12. pp. 6850-6855.
@article{5bf7a344371f4df1995e9b9aca066e48,
title = "Different mutator phenotypes in Mlh1- versus Pms2-deficient mice",
abstract = "Deficiencies in DNA mismatch repair (MMR) result in increased mutation rates and cancer risk in both humans and mice. Mouse strains homozygous for knockouts of either the Pms2 orMlh1 MMR gene develop cancer but exhibit very different tumor spectra; only Mlh1(-/-) animals develop intestinal tumors. We carried out a detailed study of the microsatellite mutation spectra in each knockout strain. Five mononucleotide repeat tracts at four different chromosomai locations were studied by using single-molecule PCR or an in vivo forward mutation assay. Three dinucleotide repeat loci also were examined. Surprisingly, the mononucleotide repeat mutation frequency in Mlh1(-/-) mice was 2- to 3-fold higher than in Pms2(-/-) animals. The higher mutation frequency in Mlh1(-/-) mice may be a consequence of some residual DNA repair capacity in the Pms2(-/-) animals. Relevant to this idea, we observed that Pms2(-/-) mice exhibit almost normal levels of Mlh1p, whereas Mlh1(-/-) animals lack both Mlh1p and Pms2p. Comparison between Mlh1(-/-) animals and Mlh1(-/-) and Pms2(-/-) double knockout mice revealed little difference in mutator phenotype, suggesting that Mlh1 nuilizygosity is sufficient to inactivate MMR completely. The findings may provide a basis for understanding the greater predisposition to intestinal cancer of Mlh1(-/-) mice. Small differences (2- to 3-fold) in mononucleotide repeat mutation rates may have dramatic effects on tumor development, requiring multiple genetic alterations in coding regions. Alternatively, this strain difference in tumor spectra also may be related to the consequences of the absence of Pms2p compared with the absence of both Pms2p and Mlh1p on as yet little understood cellular processes.",
author = "Xiang Yao and Buermeyer, {Andrew B.} and Latha Narayanan and Doan Tran and Baker, {Sean M.} and Prolla, {Tomas A.} and Glazer, {Peter M.} and Liskay, {Robert (Mike)} and Norman Arnheim",
year = "1999",
month = "6",
day = "8",
doi = "10.1073/pnas.96.12.6850",
language = "English (US)",
volume = "96",
pages = "6850--6855",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "12",

}

TY - JOUR

T1 - Different mutator phenotypes in Mlh1- versus Pms2-deficient mice

AU - Yao, Xiang

AU - Buermeyer, Andrew B.

AU - Narayanan, Latha

AU - Tran, Doan

AU - Baker, Sean M.

AU - Prolla, Tomas A.

AU - Glazer, Peter M.

AU - Liskay, Robert (Mike)

AU - Arnheim, Norman

PY - 1999/6/8

Y1 - 1999/6/8

N2 - Deficiencies in DNA mismatch repair (MMR) result in increased mutation rates and cancer risk in both humans and mice. Mouse strains homozygous for knockouts of either the Pms2 orMlh1 MMR gene develop cancer but exhibit very different tumor spectra; only Mlh1(-/-) animals develop intestinal tumors. We carried out a detailed study of the microsatellite mutation spectra in each knockout strain. Five mononucleotide repeat tracts at four different chromosomai locations were studied by using single-molecule PCR or an in vivo forward mutation assay. Three dinucleotide repeat loci also were examined. Surprisingly, the mononucleotide repeat mutation frequency in Mlh1(-/-) mice was 2- to 3-fold higher than in Pms2(-/-) animals. The higher mutation frequency in Mlh1(-/-) mice may be a consequence of some residual DNA repair capacity in the Pms2(-/-) animals. Relevant to this idea, we observed that Pms2(-/-) mice exhibit almost normal levels of Mlh1p, whereas Mlh1(-/-) animals lack both Mlh1p and Pms2p. Comparison between Mlh1(-/-) animals and Mlh1(-/-) and Pms2(-/-) double knockout mice revealed little difference in mutator phenotype, suggesting that Mlh1 nuilizygosity is sufficient to inactivate MMR completely. The findings may provide a basis for understanding the greater predisposition to intestinal cancer of Mlh1(-/-) mice. Small differences (2- to 3-fold) in mononucleotide repeat mutation rates may have dramatic effects on tumor development, requiring multiple genetic alterations in coding regions. Alternatively, this strain difference in tumor spectra also may be related to the consequences of the absence of Pms2p compared with the absence of both Pms2p and Mlh1p on as yet little understood cellular processes.

AB - Deficiencies in DNA mismatch repair (MMR) result in increased mutation rates and cancer risk in both humans and mice. Mouse strains homozygous for knockouts of either the Pms2 orMlh1 MMR gene develop cancer but exhibit very different tumor spectra; only Mlh1(-/-) animals develop intestinal tumors. We carried out a detailed study of the microsatellite mutation spectra in each knockout strain. Five mononucleotide repeat tracts at four different chromosomai locations were studied by using single-molecule PCR or an in vivo forward mutation assay. Three dinucleotide repeat loci also were examined. Surprisingly, the mononucleotide repeat mutation frequency in Mlh1(-/-) mice was 2- to 3-fold higher than in Pms2(-/-) animals. The higher mutation frequency in Mlh1(-/-) mice may be a consequence of some residual DNA repair capacity in the Pms2(-/-) animals. Relevant to this idea, we observed that Pms2(-/-) mice exhibit almost normal levels of Mlh1p, whereas Mlh1(-/-) animals lack both Mlh1p and Pms2p. Comparison between Mlh1(-/-) animals and Mlh1(-/-) and Pms2(-/-) double knockout mice revealed little difference in mutator phenotype, suggesting that Mlh1 nuilizygosity is sufficient to inactivate MMR completely. The findings may provide a basis for understanding the greater predisposition to intestinal cancer of Mlh1(-/-) mice. Small differences (2- to 3-fold) in mononucleotide repeat mutation rates may have dramatic effects on tumor development, requiring multiple genetic alterations in coding regions. Alternatively, this strain difference in tumor spectra also may be related to the consequences of the absence of Pms2p compared with the absence of both Pms2p and Mlh1p on as yet little understood cellular processes.

UR - http://www.scopus.com/inward/record.url?scp=0033535944&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033535944&partnerID=8YFLogxK

U2 - 10.1073/pnas.96.12.6850

DO - 10.1073/pnas.96.12.6850

M3 - Article

C2 - 10359802

AN - SCOPUS:0033535944

VL - 96

SP - 6850

EP - 6855

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 12

ER -